Objective: Compare the overall survival, recurrence-free survival, and complication rates between 2 comparable groups of patients operated by an endoscopic or a transfacial resection of a sinonasal adenocarcinoma.
Method: A first group of 24 patients with a sinonasal adenocarcinoma recently operated endoscopically (« ENDO », 1999 (« ENDO », -2009 ) is compared to another group of 24 patients operated anteriorly by a transfacial approach (lateral rhinotomy " LR" 1993 LR" -2007 . In this retrospective study, we included patients who would have had in 2010 an endoscopic resection.
Results: Groups were comparable in terms of age and sex (P = .49) and tumoral stages with 13T1-T2/11T3-T4 in the group ENDO and 12T1-T2/12T3-T4 in the group LR (P = .77). a total of 43 out of 48 patients have had a postoperative radiation therapy. The mean follow-up was respectively of 27 and 82 months for the groups ENDO and LR. After 27 months, the overall survival curves were not significantly different. The recurrencefree rates were equally similar in both groups (P = .71). The median duration of hospitalization was significantly shorter in the ENDO group (4 vs 8 days, P < .0001). The rate of early complications was strictly identical in both groups (3/24).
Conclusion:
The endoscopic approach is an effective treatment in selected cases of sinonasal adenocarcinomas. Early oncological outcome and morbidity are comparable to a transfacial approach. Hospitalization was significantly reduced and skin scars avoided. This procedure is less invasive but requires an optimal preoperative imaging protocol and an experienced surgical team.
Rhinology/Allergy
Epinastine Hydrochloride for Pediatric Allergic Rhinitis Hirotaka Hara, MD (presenter); Kazuma Sugahara; Makoto Hashimoto; Hiroshi Yamashita, MD Objective: 1) Prospectively evaluate the effectiveness of epinastine hydrochloride (EH) for pediatric outpatients with sleep-disordered breathing (SDB) symptoms caused by allergic rhinitis (AR); 2) Assess the quality of life (QOL) of those children prior to and following treatment with oral EH.
Method: Pediatric AR outpatients (19; boys, 9; girls, 10; average age, 5.6 years [SD = 1. 4]) with SDB symptoms were recruited. They were all treated with oral EH for 4 weeks. Before and after the 4-week treatment period, the otolaryngological findings and OSA-18 scores were collected for each participant.
Results: Epinastine hydrochloride significantly improved the swelling of the inferior nasal turbinate mucosa and decreased the quantity of nasal discharge. The initial total mean OSA-18 score was 58.5, whereas the total score reduced to 22.8 after oral epinastine hydrochloride treatment.
Conclusion: Epinastine hydrochloride therapy demonstrated positive clinical effects on both nasal findings and the QOL of pediatric outpatients with symptoms of SDB caused by allergic rhinitis. Epinastine hydrochloride therapy may improve nasal findings and QOL in pediatric outpatients with SDB symptoms.
Evolution of the Draf iii Procedure: Mucosal Grafting Technique Bryant T. Conger, MD (presenter); Kristen Riley; Bradford A. Woodworth, MD Objective: The Draf III procedure is an advanced surgical option for frontal sinus disease refractory to endoscopic frontal sinustomy and also delineates the anterior limit of skull base tumors during endoscopic resection. Our objective was to evaluate outcomes of a novel strategy utilizing mucosal grafts to decrease postoperative closure.
Method: Patients with frontal sinus pathology requiring a Draf III procedure were prospectively enrolled in the study. Demographics, reason for the procedure, percent graft viability, and ORAL PRESENTATIONS complications were recorded. The primary outcome measure was anterior-posterior (AP) diameter at 3 months.
Results: Mucosal grafting technique was performed during 19 Draf III procedures from August 2008 to November 2010. Seventeen patients (average age 54 years) were available for endoscopic measurement at 3 months with an average postoperative follow-up of 13.5 months (4-24). Reasons for the procedure included tumor (n = 9), frontal ostium stenosis (n = 7), and trauma (n = 1). Fourteen patients (83%) had complete mucosal graft viability. Average intraoperative AP diameter was 12.3 mm. All patients maintained a patent combined frontal sinus ostium for the duration of follow-up with an average diameter of 10.9 mm at 3 months and no closure >25% of intraoperative size.
Conclusion: Cicatricial stenosis and osteoneogenesis are common following the Draf III procedure in up to 50% of individuals. The present study demonstrated that the mucosal grafting technique decreases Draf III stenosis when compared with historical series and should be considered a routine strategy for preventing postoperative closure.

FESS Does Not improve lung Function in Cystic Fibrosis
Javad A. Sajan, MD (presenter); Robert Kempainen; Frank L. Rimell, MD Objective: Functional endoscopic sinus surgery (FESS) provides symptomatic relief of sinus disease in patients with CF (cystic fibrosis), but it is unclear whether it has beneficial effects on lung disease in this population. This study assessed the effect of FESS on the respiratory status of adult CF patients.
Method:
We performed a retrospective chart review at a tertiary medical center encompassing 32 adult CF patients who underwent 45 operative cases. Outcome measures were the effect of FESS on the rate of decline in lung function, intravenous antibiotic use, and hospitalization for pulmonary exacerbation.
Results: FESS was performed in 32 patients encompassing maxillary antrostomy, ethmoidectomy, frontal sinusotomy, sphenoidectomy, and polypectomy. The rate of decline in FEV1 and FVC were not significantly different in the 12 months before and after FESS. FESS did not reduce days hospitalized or days on intravenous antibiotics for a respiratory exacerbation in the pre-vs postoperative period. Limiting the analysis to the 30 surgeries that were performed in patients with concomitant respiratory symptoms did not significantly alter the results. Covariates of importance in CF, including CFTR genotype, gender, or microbiology, did not affect the study results.
Conclusion: FESS does not improve pulmonary status of adults with cystic fibrosis. These results suggest the routine use of FESS to address lung disease progression in CF patients may not be warranted.
Rhinology/Allergy
Functional Endoscopic Sinus Surgery (FESS) Alone vs FESS and Balloon Sinuplasty: A Comparative Outcome Analysis in a Pediatric Population with Chronic Rhinosinusitis
Prasad John Thottam, DO (presenter) ; Ranga R. Sirigiri; David N. Madgy, DO; Michael S. Haupert, DO; Sonal Saraiya, MD; Walter M. Belenky, MD; James Dworkin, PhD
Objective: Chronic rhinosinusitis (CRS) is a common disease afflicting children. For those affected, conventional FESS and balloon sinuplasty are surgical options for those refractory to medical management. Our objective was to evaluate whether the addition of balloon sinuplasty would improve the treatment outcome in children who undergo FESS for CRS.
Method: A 2-group, retrospective blinded chart review comparing 11 pediatric patients who underwent balloon sinuplasty to 15 undergoing FESS from 2007 to 2010 at the Detroit Medical Center. Preoperative CT scans as well as pre-and postoperative sinus symptoms and medications were compared. All group data were compared using 1-tailed independent t tests.
Results: Mean age at the time of procedure was 8.74 (SD = 4.2 years; range, 2-19 years). Both groups had similar presurgical Lund-Mackay CT CRS scores (FESS: mean = 9.33, SD = 4.7; Balloon: mean = 10.5, t = -.61, p = .55). Analyses identified posttreatment differences in symptom reduction and needed intervention between the 2 groups. Postoperatively patients who underwent balloon sinuplasty reported fewer headaches (t = 2.51, P = .01), less postnasal drip (t = 1.88, P = .04), and reduced sinus congestion (t = 2.05, P = .03). A comparison of the amount of topical steroidal/ saline and antibiotic use identified a reduction in the amount of topicals used in children who received balloon treatment (t = 2.66, P = .007) and a reduction of antibiotic use (t = 1.79, P = .04).
Conclusion:
Balloon sinuplasty directed at the frontal and maxillary sinuses resulted in better outcomes than those with traditional FESS techniques. Balloon sinuplasty patients had less sinus symptoms, required less antibiotics, and required less topical nasal steroids postoperatively. Preservation of the native anatomy in balloon sinuplasty may play a role in these findings.
